Zurich, Switzerland — Swiss pharmaceutical giant Novartis on Thursday reported soaring profits and raised its expectations for 2024 operating income, driven by strong sales for a range of its popular drugs. The firm’s net profits jumped 43 percent to $3.2 billion in the second quarter of this year, it said in a statement. Sales rose
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.